Home
Companies
Catalysts
Deep Dives
COVID-19
COVID · Infectious Disease · 2 drugs · 2 indications
SARS-CoV-2 infection.
Competitive Landscape (2 drugs)
Drug
Company
Mechanism
Modality
Route
Stage
Actemra/RoActemra
ROG.SW
IL-6 receptor antagonist
Antibody
IV/SC
APPROVED
Veklury
GILD
RNA polymerase inhibitor
Small molecule
IV
APPROVED
Indications (2)
COVID-19 hospitalized
Veklury
APPROVED
COVID-19
Actemra/RoActemra
APPROVED
Data from Supabase · Updated 2026-03-24